Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
for
Metastatic Cancer, Oligoprogressive
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT04989725
Phase2, Recruiting
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
for
Head and Neck Cancer, Oropharynx Cancer, Human Papilloma Virus
Location: Montreal, London
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT04178174
Phase3, Recruiting
A Registry for People With Lung Cancer
for
Lung Cancer, Lung Cancer Stage I
Location: Montreal, Montvale NJ, Harrison NY, Toronto, Commack NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06424327
Recruiting
PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer
for
Prostate Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: Male
Age: 18+
Code: NCT03594760
Phase3, Recruiting
Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps
for
Colorectal Cancer, Polyp of Colon
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT06807073
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Open Lung Protective Extubation Following General Anesthesia
for
Intra-abdominal Surgery, Anesthesia, Lung Injury,
Location: Montreal, Quebec, Toronto
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT06296173
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Montreal, Quebec, Boston MA, Rochester NY, Toronto,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase2, Recruiting
Neurologic Physiology After Removal of Therapy (NeuPaRT)
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
for
Breast Neoplasms, Breast Cancer
Location: Montreal, Kingston, Boston MA, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06686394
Phase1, Phase2, Recruiting
Topical Infliximab in Eyes With Penetrating Keratoplasty
for
Glaucoma Following Surgery
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 70+
Code: NCT05180994
Phase1, Phase2, Recruiting
Restrictive Fluid Management In Liver Transplantation (REFIL)